Corvus Announces Upcoming CPI-818 Data Presentations at the American Society of Hematology (ASH) Annual Meeting & Exposition

    NEXT STORY
    GeoVax Announces License Agreement With NIH to Support Continued Advancements in Vaccine Development
    PREV STORY
    Sunesis Pharmaceuticals and Viracta Therapeutics Announce Definitive Merger Agreement
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    BeiGene Announces Preliminary Clinical Data on PARP Inhibitor Pamiparib Presented at Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology

    CAMBRIDGE, Mass., and BEIJING, China, Nov. 16, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: ...

    author_avatar
    NASDAQ Market News

    Novartis drug Promacta® receives FDA Breakthrough Therapy designation for first-line use in severe aplastic anemia (SAA)

    Data supporting designation showed over half of treatment-naïve SAA patients achieved complete response with ...

    author_avatar
    NASDAQ Market News

    Arbutus Reports 2018 Third Quarter Financial Results and Provides Corporate Update

    - AB-506, a second-generation capsid inhibitor, advanced to HBV patient portion of Phase 1a/1b ...

    author_avatar
    NASDAQ Market News